[e-med] Congr�s Europ�en de M�decine Tropicale

E-MED: Congr�s Europ�en de M�decine Tropicale
-------------------------------------------------------------------------

Lisbonne
Congr�s Europ�en de M�decine Tropicale
8 - 11 septembre 2002
www.kit.de/tropical2002/

Preliminary Scientific Programme

Scientific ProgramSunday, 8 September 2002
17:00 - 18:30 Opening Ceremony
18:30 - 19:00 "Fighting Malaria" Prize
19:00 Welcome Reception
Monday, 9 September 2002
08:30 - 10:30 Plenary Session
PL1 Liability of Clinical Trials in Africa
    Chairman: William Sodeman, USA

PL2 European Platform for Clinical Trials
    Chairman: Antonio Trilla, Spain

PL3 Recent Progress in Tropical Research and Development
    Chairman: Carlos Morel, Colombia

10:30 - 11:00 Coffee-break
11:00 - 13:00 Parallel Sessions:
PS1 Global mobility: travel medicine, migration medicine and international
health (I)
    Chairmen: Louis Loutan, Switzerland
      J. Saraiva da Cunha, Portugal

PS2 Molecular and biochemical parasitology
    Chairmen: Rolf Walter, Germany
      Jaime Nina, Portugal
    Keynote Speaker: Sylke Mueller, Germany

PS3 Pathophysiology in malaria and malaria in pregnancy
    Chairmen: Umberto D'Alessandro, Belgium
      Virg�lio do Ros�rio, Portugal
    Keynote Speaker: Bernard Brabin, UK

    Workshops:
W1 Chagas disease, domiciliary vector eradication programme
    Chairman: Chris Schofield, UK

W2 Schistosomiasis control in Subsaharian Africa
    Chairman: Pierre Ambroise-Thomas, France

W3 Host Pathogens Interactions
    Chairman: Virg�lio do Ros�rio, Portugal

13:00 - 14:30 Lunch & Poster Display
14:30 - 16:00 Symposium 1
    Diagnostics of imported virus infections, a European network
    Chairman: Matthias Niedrig, Germany

    The need for a European Centre of infectious diseases
    Chairman: M. Tibayrenc, France

    Ethical issues in tropical medicine research
    Chairman: Henri van Asten, Netherlands

    Insecticide resistance of vectors
    Chairman: Janet Hemingway, UK

    Snake bites and scorpion toxins
    Chairman: Max Goyffon, France

16:00 - 16:30 Coffee-break
16:30 - 18:30 Parallel sessions:
PS4 Global mobility: travel medicine, migration medicine and international
health ( II)
    Chairmen: Louis Loutan, Switzerland
      J. Saraiva da Cunha, Portugal

PS5 Human resources for health
    Chairmen: Tim Martineau, UK
      Pereira Miguel, Portugal
    Keynote Speaker: Carlsten Mantell, Germany

PS6 Molecular epidemiology and field application
    Chairmen: Hans Peter Beck, Switzerland
      Olga Matos , Portugal

PS7 Advocacy for control of tropical diseases
    Chairmen: Catherine Hogdkin
      Jorge Torgal , Portugal
    Keynote Speaker: Steve Connor, UK

    Workshop:
WS4 Ectoparasitic diseases of poverty
    Chairman: Hermann Feldmeier, Germany
17:00 - 18:30 Satellite Symposium Sanofi-Synthelabo/Impact Malaria
    Welcome and Opening Remarks
    Chairman: William M Watkins
    .Initial management of severe malaria in children : use of rectal
formulations of antimalarials.
    Ogobara K Doumbo
    .Bioavailability, efficacy and tolerance of intrarectal administration of
Quinimax� in children.
    Hubert Barennes
    .Quinimax� Intrarectal : presentation of an emergency
    Val�rie Lameyre
    .Insight into practical use of Quinimax� Intrarectal with Malaria Control
Programs.
    Aly M Thera

Tuesday, 10 September 2002
08:30 - 10:30 Plenary Session
PL4 Tuberculosis-Multiple Drug Resistance
    Chairman: Eduardo Gotuzzo, Peru

PL5 Guinea Worm Eradication Program: The State of the Art
    Chairman: Marc Karam, France

PL6 Progress of the Global Programme for the Elimination of Lympatic
Filariasis
    Chairman: David Molyneux, UK

PL7 Malaria Vaccines in Africa
    Chairman: Wen Kilama, Tanzania
10:30 - 11:00 Coffee-break
11:00 - 13:00 Parallel Sessions:
PS8 Onchocerciasis
    Chairmen: Rory Post, UK
      Ant�nio Gra�o , Portugal

PS9 Schistosomiasis control
    Chairmen: Pascal Magnussen, Denmark
      Am�lia Gr�cio, Portugal

PS10 Immunology of tropical parasitic diseases (I)
    Chairmen: Farrokh Modabber
      Celso Cunha, Portugal
    Keynote speaker: Frank Brombacher, South Africa

PS11 HIV and Opportunistic Pathogens
    Chairmen: Emil Reisinger, Germany
      Francisco Antunes, Portugal
    Keynote speaker: Matthias Lademann

PS12 Leishmaniasis
    Chairmen: Dick Ashford, UK
      Lenea Campino, Portugal

    Workshop:
WS5 Anti-malarial drugs of the future
    Chairman: Pierre Ambroise-Thomas, France
13:00 - 14:30 Lunch & Poster Display
14:30 - 16:00 Symposium 2
    Access to Essential Drugs in Developing Countries
    Speaker: Patrice Trouiller, France

    Antiretroviral treatment in resource-poor countries
    Speaker: Robert Colebunders, Belgium

    NGO's role in tropical medicine in developing countries
    Speaker: B. Pecoul, France

    Potential for natural drugs
    Speaker: Merlin Willcox, UK

    Antibacterial resistance in developing countries (except tuberculosis)
    Speaker: V. Kern, Germany
16:00 - 16:30 Coffee-break
16:30 - 18:30 Parallel sessions:
PS13 Immunology of tropical parasitic diseases (II)
    Chairmen: Farrokh Modabber
      Celso Cunha, Portugal

PS14 Tuberculosis control
    Chairmen: Martin Boeree, Netherlands
      Miguel Viveiros, Portugal

PS15 Human Fascioliasis: An emerging disease
    Chairmen: Dolores Bargues, Spain
      Am�lia Gr�cio, Portugal
    Keynote speaker: Santiago Mas-Coma, Spain
    Workshops:
WS6 Lymphatic filariasis : progress towards the elimination goal
    Chairman: David Molyneux, UK

WS7 Rational use and new formulations in malaria chemotherapy
    Chairman: William Watkins, UK

WS8 Molecular tools in Tropical Health
    Chairman: Guilherme Ferreira, Portugal
16:30 - 18:30 Satellite Symposium
    GlaxoSmithKline
Wednesday, 11 September 2002
08:30 - 10:30 Plenary Session
PL8 Programme to Eradicate Tse Tse and Trypanosomiasis
    Chairman: John Kabayo, Uganda

PL9 Leishmania/HIV Infection
    Chairman: Philippe Desjeux, Switzerland

PL10 Roll Back Malaria
    Chairman: D Alnwick, UK
10:30 - 11:00 Coffee-break
11:00 - 13:00 Parallel Sessions:
PS16 African Trypanosomiasis : Drug development and clinical trials
    Chairmen: Jean Jannin, Switzerland
      Jorge Atouguia, Portugal

PS17 Malaria vector ecology and control
    Chairmen: Marc Coosemans, Belgium
      Pedro Almeida, Portugal

PS18 Non tuberculosis mycobacterial infections
    Chairmen: Fran�oise Portaels, Belgium
      Kamal Mansinho, Portugal

PS19 Zoonoses
    Chairmen: Dick Ashford, UK
      Margarida Collares Pereira, Portugal

PS20 Malaria Treatment
    Chairmen: Sornchai Looareesuwan, Thailand
      Francisco Antunes, Portugal

    Workshop:
WS9 Tick-borne diseases
    Chairman: Jan Kazar, Slovakia
13:00 - 14:30 Lunch & Poster Display
14:30 - 16:00 Symposium 3
    Emerging bacterial and viral pathogens
    Chairman: Michel Drancourt, France

    Emerging parasitic and mycotic infections
    Chairman: Martin Grobusch, Germany

    Viral haemorrhagic fevers
    Chairman: Matthias Borchert, Belgium

    Amebiasis : laboratory diagnosis today
    Chairman: Tony Vervoort, Belgium

    Cysticercosis
    Chairman: Pierre Dorny, Belgium
16:00 - 16:30 Coffee-break
16:30 - 18:30 Parallel sessions:
PS21 Meningococcal Meningitis
    Chairmen: Suzanne Chanteau, France
      Filomena Exposto, Portugal

PS22 Vector bioecology and control
    Chairmen: Pierre Carnevale, France
      Ant�nio Gr�cio, Portugal
  Keynote speaker: Pierre Guillet, France
    Paul Brey, France

PS23 Update on vaccines for tropical diseases
    Chairmen: S�ren Jepsen, Denmark
      Virg�lio do Ros�rio, Portugal

PS24 Genetics of parasites drug resistance
    Chairmen: Jean-Claude Dujardin, France
      Henrique Silveira, Portugal
    Keynote speaker: Peter Winstanley, UK

PS25 Evidence based clinical management
    Chairmen: Thomas Junghanss, Germany
      Kamal Mansinho, Portugal

PS26 Health systems in resource Poor countries and crisis
    Chairmen: Rolf Korte, Germany
      Aldina Gon�alves, Portugal
    Workshop:
    PATTEC (Pan African tsetse and trypanosome eradication campaign)
    Chairman: Chris Schofield, UK
18:30 - 19:00 Closing Ceremony

--
Adresse pour les messages destin�s au forum E-MED:
<e-med@usa.healthnet.org>
Pour r�pondre � un message envoyer la r�ponse au forum
ou directement � l'auteur.
Pour toutes autres questions addresser vos messages � :
<e-med-help@usa.healthnet.org>